Drug Conjugate Software Available In Latin America
1 software items found
-
by Certarabased in USA
Biological medicines (“biologics” or “large molecule drugs”) now account for 30% of new drug approvals and up to 50% of the pharmaceutical industry’s pipeline. Biologics differ from small molecules because they are much larger, have slower absorption rates, confined distribution, and different ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you